Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
NCT02832245 · View on ClinicalTrials.gov ↗
Study Summary
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.
Conditions Studied
Study Locations (20)
Buenos Aires
- Clínica San Camilo — Buenos Aires
- Hospital Italiano de Buenos Aires — Buenos Aires
- Clínica Privada Pueyrredón — Mar del Plata
Beijing Municipality
- The Seven Medical Center of Chinese PLA General Hospital — Beijing
- Peking University Cancer Hospital and Institute — Beijing
Connecticut
- Yale University School of Medicine — New Haven
Florida
- College of Medicine - Jacksonville University of Florida — Jacksonville
Illinois
- Evanston NorthShore University HealthSystem — Evanston
Massachusetts
- Massachusetts General Hospital — Boston
New York
- Northwell Health System — Manhasset
Wisconsin
- Medical College of Wisconsin — Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120,000 participants |
| Start Date | 2001-03 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832245
The ClinicalTrials.gov registry entry for NCT02832245 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 120,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Manuel Monreal, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02832245 reports 20 study locations spanning 17 distinct geographic areas — top geographies include Buenos Aires, Beijing Municipality, Connecticut. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02832245 about?
NCT02832245 is a clinical study titled "Computerized Registry of Patients With Venous Thromboembolism (RIETE)". The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet t...
What is the current status of trial NCT02832245?
This trial is currently recruiting. The enrollment target is 120,000 participants. The study started on 2001-03. Estimated completion is 2027-12.
What conditions does trial NCT02832245 study?
This clinical trial studies the following conditions: Venous Thromboembolism. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT02832245?
This trial is sponsored by Manuel Monreal, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02832245 being conducted?
This trial has 20 study locations across Connecticut, Florida, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.